Our vision is of a world where humans are healthier because diseases are identified faster and treated/cured sooner through the use of assays that employ advanced sequencing technologies.
Fusion Genomics is a molecular diagnostics company focused on transforming infectious disease through advanced genomic technologies. Fusion is applying novel DNA/RNA capture and informatics technologies to overcome the limitations of current infectious-disease diagnostic tests, with the aim of preventing unnecessary deaths from infectious disease and halting the growing problem of drug resistance. The company’s rapid, highly sensitive, and cost-effective next-generation sequencing (NGS)-based tests have the potential to disrupt the $8 billion global infectious disease diagnostics market, replacing many conventional and molecular clinical lab tests.
Industry - Life Science & Digital Health
